Events, News, Presentations, Press Releases
Sutro Biopharma to Participate in the Jefferies Healthcare Conference SOUTH SAN FRANCISCO, Calif., May 31, 2023 – Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug...
Events, News, Presentations
2023 American Society of Pediatric Hematology / Oncology (ASPHO) Annual Meeting – Poster A Novel Therapy for Refractory CBFA2T3::GLIS2-associated AMKL Using STRO-002 And Plerixafor...
Events, News, Presentations, Press Releases
Sutro Biopharma to Present at the JMP Securities Life Sciences Conference SOUTH SAN FRANCISCO, Calif., May 8, 2023 – Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug...
Events, News, Presentations
2023 American Association for Cancer Research Annual Meeting (AACR) – Poster Abstract #4849: The anti-ROR1 ADC STRO-003 demonstrates immune-modulating properties that may enhance checkpoint blockade Andrew McGeehan, Sihong Zhou, Dayson Moreira, Robert Yuan, Indrani...
Events, News, Presentations, Press Releases
Sutro Biopharma Presents Preclinical Data for its ROR1 Targeting Antibody Drug Conjugate STRO-003 at the AACR Annual Meeting 2023 ORLANDO, FL— April 18, 2023 — Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering...
Events, News, Presentations
13th Annual World ADC London 2023 – Presentation Novel Precise Homosgenous ADCs Presented by: Kristin Bedard, SVP Drug Discovery...
